Florian Babor

Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

MRI paving the way to diagnosis of acute lymphoblastic leukemia in children and adolescents - a retrospective observational study.

MRI paving the way to diagnosis of acute lymphoblastic leukemia in children and adolescents - a retrospective observational study.

Journal: Molecular and cellular pediatrics

Published: April 21, 2026

Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.

Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.

Journal: Neuro-oncology practice

Published: May 28, 2025

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.

Journal: Blood advances

Published: February 10, 2025

Life-Threatening Infantile Fibrosarcoma in an Infant.

Life-Threatening Infantile Fibrosarcoma in an Infant.

Journal: Pediatric blood & cancer

Published: January 22, 2025

SOCS1 deficiency-crossroads of autoimmunity and autoinflammation-two case reports.

SOCS1 deficiency-crossroads of autoimmunity and autoinflammation-two case reports.

Journal: Frontiers in pediatrics

Published: October 23, 2024

Alpha/beta values in pediatric medulloblastoma: implications for tailored approaches in radiation oncology.

Alpha/beta values in pediatric medulloblastoma: implications for tailored approaches in radiation oncology.

Journal: Radiation oncology (London, England)

Published: July 08, 2024

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.

Journal: The Lancet. Oncology

Published: December 18, 2023

A Diagnostic Strategy for Gauging Individual Humoral Ex Vivo Immune Responsiveness Following COVID-19 Vaccination.

A Diagnostic Strategy for Gauging Individual Humoral Ex Vivo Immune Responsiveness Following COVID-19 Vaccination.

Journal: Vaccines

Published: May 30, 2022

Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Journal: Journal of clinical immunology

Published: May 02, 2022

CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.

CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.

Journal: Frontiers in immunology

Published: October 19, 2021

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.

Journal: Cancer immunology, immunotherapy : CII

Published: September 07, 2021

Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Journal: Journal of clinical immunology

Published: June 08, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026